Chlamydia pneumoniae & Alzheimer’s: A Potential Link
Unraveling the Link: How COVID-19 and Bacterial Infections May Accelerate Alzheimer’s Disease
Table of Contents
New research from the Philadelphia College of Osteopathic Medicine (PCOM) is shedding light on a potential, albeit complex, connection between infectious agents and the advancement of Alzheimer’s disease. The study, which examined peer-reviewed literature, suggests that infections, including the bacterium Chlamydia pneumoniae (Cpn) and the virus SARS-CoV-2 (the virus responsible for COVID-19), may play a meaningful role in the pathogenesis of this neurodegenerative condition.
The Interplay of Infections and Neuroinflammation
The research delves into the intricate relationship between specific pathogens and the biological processes associated with Alzheimer’s disease. It highlights how these infections can trigger or exacerbate neuroinflammation, a key factor in the progression of the disease.
Understanding the Mechanisms
The PCOM study meticulously reviewed existing scientific literature, focusing on the associations between Cpn and SARS-CoV-2 with Alzheimer’s disease. A critical aspect of this review involved considering genetic risk factors, such as the APOEε4 gene variant, and specific biomarkers like IL-6, CCL2, and NRP1. These elements are crucial for understanding how infections can impact the brain’s structure and function, leading to neuroinflammation.
The findings indicate that individuals carrying the APOEε4 gene variant may be particularly susceptible to both Cpn and SARS-CoV-2 infections. This heightened susceptibility could, in turn, amplify their risk of developing Alzheimer’s disease.
The Role of the Olfactory Pathway
One significant pathway explored by researchers is the olfactory system.Pathogens can invade the body through the nasal cavity, reaching the brain via the olfactory nerve. This specialized pathway allows microbes to travel directly to the central nervous system, potentially initiating or contributing to neuroinflammation. The speed at which some pathogens can reach the brain through this route is a point of particular interest for ongoing studies.
Biomarkers and Inflammation
The research also emphasizes the role of specific proteins and inflammatory markers. As a notable example, elevated levels of IL-6 (Interleukin-6) are frequently enough observed in individuals with Alzheimer’s disease and are linked to increased inflammation. the study suggests that infections can lead to an increase in such inflammatory substances, further contributing to the damage seen in the brain.
Expert Insights and Future Directions
Brian J. Balin, PhD, a professor of Neuroscience and Neuropathology at PCOM and director of the Center for Chronic Disorders of Aging (CCDA), co-authored the report. He expressed the significance of these findings in advancing our understanding of Alzheimer’s disease.
“These findings bring us one step closer to understanding the complex interactions between infections and Alzheimer’s disease,” stated Dr.Balin. “As we continue to learn more about the role infectious agents play in the development of this disease,we hope to create new avenues for prevention and treatment.”
Dr. Balin and his team have dedicated over two decades to exploring the hypothesis that infectious agents could be a trigger for the pathological processes that lead to the accumulation of amyloid and tau proteins-hallmarks of Alzheimer’s disease. To further investigate these connections, PCOM recently established its Pathobiome Research Center, aiming to examine the links between infectious processes and other chronic disorders, including Alzheimer’s.
implications for Prevention and Treatment
The ongoing research into the link between infections and Alzheimer’s disease holds significant promise for developing novel strategies for prevention and treatment. By identifying specific pathogens and understanding their mechanisms of action within the brain, scientists may be able to develop targeted therapies or preventative measures to mitigate the risk of developing this devastating neurodegenerative condition.
Source: Philadelphia College of Osteopathic Medicine (PCOM)
Journal Reference: Romanella,A., et al. (2025). infections with Chlamydia pneumoniae and SARS-CoV-2 and alzheimer’s disease pathogenesis. Frontiers in Aging Neuroscience. doi.org/10.3389/fnagi.2025.1587782.